WallStreetZenWallStreetZen

NASDAQ: ESPR
Esperion Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Esperion Therapeutics earnings were -$153.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ESPR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$40.5M, up 89.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ESPR reported annual earnings of -$51.7M, with -75.3% growth.

ESPR earnings history

Current Revenue
$259.6M
Current Earnings
-$153.2M
Current Profit Margin
-59%

ESPR Return on Equity

Insufficient data to display

ESPR undefined

Current Company
-45.9%
Current Industry
6.9%
ESPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ESPR announces earnings.

ESPR undefined

Current Company
-166.9%
Current Industry
14.3%
ESPR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ESPR vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ESPR-$88.48M-$153.22MN/A-$0.80
OGI$22.38M$12.19MN/A$0.04
CGC-$391.33M-$427.23MN/A-$3.97
DERM-$1.43M-$8.30MN/A-$0.39
ACB$26.15M$172.99kN/A$0.03
View Top Pharmaceutical Stocks

Esperion Therapeutics Earnings Reports & History FAQ

What were Esperion Therapeutics's earnings last quarter?

On ESPR's earnings call on Invalid Date, Esperion Therapeutics (NASDAQ: ESPR) reported Q1 2025 earnings per share (EPS) of -$0.21, up 158.33% year over year. Total ESPR earnings for the quarter were -$40.46 million. In the same quarter last year, Esperion Therapeutics's earnings per share (EPS) was $0.36.

If you're new to stock investing, here's how to buy Esperion Therapeutics stock.

Is Esperion Therapeutics profitable or losing money?

As of the last Esperion Therapeutics earnings report, Esperion Therapeutics is currently losing money. Esperion Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$153.22 million, a 77.12% increase year over year.

What was ESPR's earnings growth in the past year?

As of Esperion Therapeutics's earnings date in Invalid Date, Esperion Therapeutics's earnings has grown year over year. ESPR earnings in the past year totalled -$153.22 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.